SCHEMBL6787409

SCHEMBL6787409

O=C(/C=C/C=C/c1ccc(C(F)(F)F)cc1)N1CCCN(C(=O)/C=C/C=C/c2ccc(C(F)(F)F)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
GPR183 P32249 3/20 0.57
LMNA P02545 3/20 0.57
TP53 P04637 3/20 0.57
ALOX5 P09917 3/20 0.54
MAOB P27338 2/20 0.54
CYP1A2 P05177 2/20 0.54
MAPT P10636 2/20 0.54
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
HPGD P15428 3/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP3A4 P08684 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
CTSD P07339 1/20 0.50
ABCB1 P08183 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6785345 0.86 ALDH1A1 (0.72) ALDH1A1GPR183LMNATP53ALOX5
SCHEMBL5572606 0.86 GPR183 (0.52) ALDH1A1GPR183LMNATP53ALOX5
SCHEMBL5572610 0.86 GPR183 (0.52) ALDH1A1GPR183LMNATP53ALOX5
Hydrochloric Acid SCHEMBL5573111 0.85 GPR183 (0.51) ALDH1A1GPR183LMNATP53ALOX5
Hydrochloric Acid SCHEMBL5573117 0.85 GPR183 (0.51) ALDH1A1GPR183LMNATP53ALOX5
SCHEMBL6792908 0.84 LMNA (0.56) ALDH1A1LMNATP53ALOX5MAOB
SCHEMBL6786005 0.84 ALDH1A1 (0.80) ALDH1A1GPR183LMNATP53ALOX5
SCHEMBL7679652 0.81 GAA (0.62) ALDH1A1GPR183LMNATP53ALOX5
SCHEMBL6785637 0.81 MEN1 (0.79) ALDH1A1LMNATP53ALOX5MAOB
SCHEMBL19385657 0.80 GPR183 (0.67) ALDH1A1GPR183LMNATP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 ALDH1A1 836/4885GPR183 1153/4885LMNA 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.